Shionogi Logs Record Profits as Xocova Nets 100 Billion Yen from Govt Purchase: April-December

January 31, 2023
Shionogi delivered sharp revenue growth and record profits in April-December 2022 as it hauled in sales of 100 billion yen from the government purchase of its COVID-19 pill Xocova (ensitrelvir), according to its earnings released on January 30. In the...read more